In multiple sclerosis, N-acetylglucosaminyltransferase I (Mgat1) expression and N-glycan branching are enhanced by vitamin D3 treatment, therefore inhibiting CTLA-4 internalization and increasing the surface expression of CTLA-4 in T-cells [73]. This evidence concerns the gene CTLA4 and multiple sclerosis.